MSU co-authored study: 10 insights to reduce vaccine hesitancy on social media

Young Anna Argyris, associate professor in the Michigan State University Department of Media and Information, is part of an international team studying the detrimental effects of vaccine misinformation on social media and interventions that can increase vaccine uptake behaviors.

Pharmacology Expert Comments on RSV Vaccination Errors

The Centers for Disease Control and Prevention (CDC) reports that some pregnant Americans may have been given the wrong RSV vaccine, and some young children received a vaccine approved for use in adults only.  Now, a pharmacology expert at New York Institute…

Infectious Disease Expert Available: Flu Season, COVID-19 Variant and other Respiratory Viruses

In the United States, flu season usually occurs in the fall and winter, and while influenza viruses spread year-round, most of the time flu activity peaks between December and February. The overall impact of the flu varies from season to…

MSU expert: What to know about flu, RSV, new COVID-19 variant and new vaccine

The new COVID-19 EG.5 variant is responsible for around 22% of current cases. The World Health Organization has classified it as a “variant of interest,” meaning countries should monitor it more closely than other strains — and cases have only increased in the past few weeks. Peter Gulick is an expert on infectious diseases, and he provides insight on what this new variant could mean and what you should know.

Dr. Carol Nwelue discusses how to keep your kids healthy when going back to school.

Carol Nwelue, MD, at Baylor Scott & White Health, answers common patient questions and reacts to the latest medical research. How can parents keep their kids healthy this back-to-school season? (SOT@ 0:14, TRT 0:34) Why do sicknesses spread easily when…

Asymptomatic infections may underlie recent rise in whooping cough

In a new study, scientists at La Jolla Institute for Immunology (LJI) compared the immune response of individuals who received older versus newer versions of the whooping cough vaccine. The unexpected findings may help explain the recent rise in whooping cough cases and point to potential targets for the next generation of vaccines.

UC San Diego Health Experts Available to Discuss Shingles, Ramsay Hunt Syndrome

California Sen. Dianne Feinstein has developed rare complications due to a months-long shingles infection, including encephalitis (brain inflammation) and Ramsay Hunt Syndrome. Ramsay Hunt Syndrome occurs when shingles infects cranial nerves, including the auditory, vestibular and facial nerves, which can…

Breakthrough COVID-19 cases occur in 7.5% of vaccinated Texas participants, according to UTHealth Houston survey; subgroups at higher risk identified

Breakthrough COVID-19 infections after vaccination occurred in 7.5% of Texans surveyed and were linked to Hispanic ethnicity, larger household size, rural versus urban living, type of vaccination, and multiple comorbidities, according to findings from UTHealth Houston School of Public Health published today in the Journal of Infectious Diseases.

Two UCI researchers named fellows by the National Academy of Inventors

Irvine, Calif., Dec. 8, 2022 — The National Academy of Inventors has named two University of California, Irvine researchers as fellows for 2022. Philip Felgner, a pioneer in the development of lifesaving mRNA vaccines, and Payam Heydari, a prolific creator of cutting-edge microelectronics technologies, were both recognized for inventions that have made tangible impact on quality of life, economic development and the welfare of society.

Needs and Challenges for COVID-19 Boosters and Other Vaccines in the U.S.

FAU researchers and collaborators provide the most updated guidance to health care providers and urge how widespread vaccination with these boosters can now avoid the specter of future and more lethal variants becoming a reality.

Cancer Patients Treated with Immunotherapy Can Safely Receive mRNA COVID-19 Vaccines, According to JNCCN Study

New research published in the October 2022 issue of JNCCN—Journal of the National Comprehensive Cancer Network confirms the safety of mRNA vaccines in people with cancer undergoing immunotherapy treatment.

Mount Sinai Announces the Formation of CastleVax Inc., a Clinical-Stage Infectious Diseases Company Developing Novel Vaccines and Therapeutics, Targeting Pandemic Threats and Diseases of Unmet Medical Need

The Mount Sinai Health System has launched CastleVax, Inc. (“CastleVax”), a clinical-stage vaccine research and development company.

Immune Molecules From a Llama Could Provide Protection Against a Vast Array of SARS-like Viruses Including COVID-19, Researchers Say

Mount Sinai-led researchers have shown that tiny, robust immune particles derived from the blood of a llama could provide strong protection against every COVID-19 variant, including Omicron, and 18 similar viruses.

University of Pennsylvania’s First NFT Commemorates mRNA Research

The historic scientific breakthrough at the Perelman School of Medicine at the University of Pennsylvania that helped lead the world’s fight against COVID-19 through mRNA-based vaccines is being commemorated through a non-fungible token—a digital asset to be auctioned by Christie’s—that will support ongoing research at Penn.

SEIR Model to Address the Impact of Face Masks amid COVID-19 Pandemic

When vaccines are not available, alternative strategies are required to decrease SARS-CoV-2 transmission. Behavior of the population and government regulations, such as hand hygiene, quarantine of exposed persons, isolation of symptomatic persons, and travel restriction, play an essential role in…

The US reaches 1 Million Deaths from COVID-19: GW Experts Available to Comment

The United States has reached 1 million reported deaths from COVID-19 and that number is likely an undercount, according to the Centers for Disease Control and Prevention. The George Washington University has a number of experts to comment on the…

UCI professor wins prestigious Robert Koch Prize for groundbreaking research

Irvine, Calif., April 27, 2022 – Philip Felgner, Ph.D., professor in residence of physiology & biophysics at the University of California, Irvine, is one of two scholars to win the prestigious 2022 Robert Koch Prize for fundamental contributions to the transfer of nucleic acids into cells. This pioneering technology for treating infectious diseases played a crucial role in developing the messenger RNA COVID-19 vaccines.